Sustained-release formulation
AssigneeTakeda Pharmaceutical Company Limited
InventorsTomomichi Futo, Hikaru Taira, Seitaro Mizukami, Naoyuki Murata
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsTomomichi Futo, Hikaru Taira, Seitaro Mizukami, Naoyuki Murata
Estimating the term…
The present invention relates to a sustained-release formulation comprising a metastin derivative and a lactic polymer having a weight average molecular weight of about 5,000 to about 40,000 or a salt thereof. The sustained-release formulation of the present invention slowly and stably releases compound (I) or a salt thereof over a long period of time and exerts medicinal effects of compound (I) or a salt thereof over a long period of time. Furthermore, the sustained-release formulation of the present invention, which improves patient's convenience by reducing frequency of administration, is an excellent formulation as a clinical medicine.
A sustained-release formulation comprising a compound represented by Formula:
A method for treating or preventing cancer comprising administering an effective amount of the sustained-release formulation according to clam 1 to a mammal.
Dependencies are inferred from the claim text.